E
Ennio Tasciotti
Researcher at Houston Methodist Hospital
Publications - 216
Citations - 9469
Ennio Tasciotti is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Drug delivery & Tissue engineering. The author has an hindex of 42, co-authored 212 publications receiving 7526 citations. Previous affiliations of Ennio Tasciotti include University of Akron & Open University.
Papers
More filters
Journal ArticleDOI
Effects of the protein corona on liposome-liposome and liposome-cell interactions.
Claudia Corbo,Roberto Molinaro,Francesca Taraballi,Naama E. Toledano Furman,Michael B. Sherman,Alessandro Parodi,Francesco Salvatore,Ennio Tasciotti +7 more
TL;DR: In an attempt to better understand the interactions between nanocarriers and biological systems, the plasma proteins adsorbed on the surface of multicomponent liposomes were analyzed and the physical properties and ultrastructure of liposome/PC complexes and the aggregation process that occurs whenliposomes are dispersed in plasma were analyzed.
Journal ArticleDOI
A biomimetic 3D model of hypoxia-driven cancer progression.
Chiara Liverani,Alessandro De Vita,Silvia Minardi,Yibin Kang,Laura Mercatali,Dino Amadori,Alberto Bongiovanni,Federico La Manna,Toni Ibrahim,Ennio Tasciotti +9 more
TL;DR: This biomimetic model mimics the evolution of tumors with different grade of aggressiveness fostered by a hypoxic niche and provides a relevant technology to dissect the events involved in cancer progression.
Journal ArticleDOI
Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation.
Bruna Corradetti,Francesca Taraballi,Jonathan O. Martinez,Silvia Minardi,Nupur Basu,Guillermo Bauza,Guillermo Bauza,Michael Evangelopoulos,Sebastian T. Powell,Claudia Corbo,Ennio Tasciotti,Ennio Tasciotti +11 more
TL;DR: A simple and versatile method to transiently overexpress the hyaluronic acid (HA) receptor, CD44, on MSC membranes, to improve their homing potential towards an inflammatory site without affecting their behavior is reported.
Journal ArticleDOI
Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.
Roberto Molinaro,Roberto Molinaro,Jonathan O. Martinez,Assaf Zinger,Alessandro De Vita,Gianluca Storci,Gianluca Storci,Noemi Arrighetti,Enrica De Rosa,Kelly A. Hartman,Nupur Basu,Nima Taghipour,Claudia Corbo,Claudia Corbo,Ennio Tasciotti +14 more
TL;DR: The use of leukosomes is reported to target and deliver doxorubicin, a model chemotherapeutic, to tumors in syngeneic murine models of breast cancer and melanoma models, demonstrating the promise of using biomimetic nanovesicles for effective cancer management in solid tumors.
Journal ArticleDOI
Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat
TL;DR: It is reported that fusion of TK to an 11-amino-acid peptide from the basic domain of the HIV-1 Tat protein (Tat11) imparts cell membrane translocating ability to the enzyme and significantly increases its cytotoxic efficacy.